Roberto Berni Canani | Molecular Medicine | Best Researcher Award

Published on by Molecular Biologist

Prof. Roberto Berni Canani | Molecular Medicine | Best Researcher Award 

Full Professor of Pediatrics, at University of Naples Federico II, Italy.

Prof. Dr. Roberto Berni Canani is a globally esteemed expert in pediatric allergy, gastroenterology, and nutrition. He holds the position of Full Professor of Pediatrics at the University of Naples “Federico II” and leads multiple pivotal programs, including the Pediatric Allergy Gastroenterology and Nutrition Program, ImmunoNutritionLab at CEINGE Advanced Biotechnologies, and NutriTechLab. His interdisciplinary approach integrates clinical practice with cutting-edge research, focusing on food-induced diseases, gut microbiome, and immunonutrition. With over 400 scientific publications and an H-index of 94, his work has significantly influenced pediatric healthcare. Prof. Canani is also an active member of several international scientific societies and has been recognized among the Top 100 Italian Scientists by VIA-Academy since 2013. Biocodex Microbiota Institute

Professional Profile

Scopus

ORCID

Google Scholar

🎓 Education

Prof. Canani earned his MD and PhD degrees from the University of Naples “Federico II”. His doctoral research delved into the pathophysiology of acute and chronic intestinal diseases, laying the foundation for his future endeavors in pediatric gastroenterology and nutrition. He further specialized in Pediatrics, obtaining board certification, and pursued advanced training through research fellowships and visiting professorships at esteemed institutions such as Harvard Medical School, University of Chicago, and Cincinnati Children’s Hospital. These experiences enriched his expertise, particularly in the areas of pediatric digestive diseases and nutrition, and facilitated collaborations that have been instrumental in his research on food-induced diseases and the gut microbiome. ResearchGate

💼 Experience

With a career spanning over three decades, Prof. Canani has been at the forefront of pediatric healthcare and research. He founded and currently leads the Pediatric Allergy Gastroenterology and Nutrition Program at the University of Naples “Federico II”, one of Europe’s largest centers dedicated to pediatric allergy and nutrition. Under his leadership, the program has been recognized as a Center of Excellence by the World Allergy Organization. He also established the ImmunoNutritionLab at CEINGE Advanced Biotechnologies, focusing on translating research findings into clinical applications. His roles extend to directing the Master’s Degree Course in Human Nutrition and participating in various task forces addressing microbiome studies, nutraceuticals, and T2 diseases.

🔬 Research Interests

Prof. Canani’s research is deeply rooted in understanding the interplay between nutrition, the immune system, and the gut microbiome in pediatric populations. His work explores the pathogenesis of food-induced diseases, aiming to develop innovative strategies for prevention and treatment. Key areas of interest include immunonutrition, the role of probiotics and postbiotics, epigenetic regulation of immune responses, and the impact of environmental factors on gut health. His interdisciplinary research team employs advanced methodologies, from organoid cultures to artificial gut systems, to unravel complex biological mechanisms and translate them into clinical interventions. ceinge.unina.it

🏆 Awards

Prof. Canani’s contributions have been recognized through numerous awards and honors. He has received several scientific prizes for his research activities and has been a member of the Expert Panel and the Dietetic Products, Nutrition, and Allergies Panel of the European Food Safety Authority (EFSA). Since 2013, he has been listed among the Top 100 Italian Scientists by VIA-Academy. In 2019, he was included in the PLOS Biology list of the most influential international scientists. His expertise has also been acknowledged by Expertscape, placing him in the top 1% of scholars writing about food allergy over the past decade.

📚 Top Noted Publications

Prof. Canani has authored over 400 scientific publications, contributing significantly to the fields of pediatric allergy, gastroenterology, and nutrition. His work is widely cited, with more than 44,000 citations and an H-index of 94. Below are some of his notable publications:

1. Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants

  • Journal: ISME Journal, 2016; 10(3):742–750

  • Citations: 200+

  • Key Insight: Supplementation with L. rhamnosus GG (LGG) increases butyrate-producing strains, indicating a protective microbiota profile in allergic infants.

2. Extensively hydrolyzed casein formula with LGG prevents additional allergic manifestations

  • Journal: Journal of Allergy and Clinical Immunology, 2017; 139(6):1906–1913.e4

  • Citations: 150+

  • Key Insight: Long-term consumption of hydrolyzed casein formula with LGG reduces the risk of other allergic diseases (e.g., eczema, asthma).

3. Altered miR-193a-5p expression in children with cow’s milk allergy

  • Journal: Allergy, 2018; 73(2):379–386

  • Citations: 100+

  • Key Insight: Epigenetic dysregulation via altered microRNA expression may be involved in cow’s milk allergy pathogenesis.

4. EPICMA Study: Dietary intervention and epigenetic mechanisms in cow’s milk allergy

  • Journal: Scientific Reports, 2019; 9(1):2828

  • Citations: 80+

  • Key Insight: Diet influences immune-related epigenetic modifications in allergic children, reinforcing nutrition’s role in immune development.

5. Healthy infants harbor intestinal bacteria that protect against food allergy

  • Journal: Nature Medicine, 2019; 25(3):448–453

  • Citations: 300+

  • Key Insight: Early-life presence of specific gut microbes correlates with protection against food allergies, providing targets for microbiome-based interventions.

6. Targeting Food Allergy with Probiotics

  • Book Chapter: Advances in Experimental Medicine and Biology, 2019

  • Citations: 50+

  • Key Insight: Reviews probiotic strategies for modulating immune responses and reducing food allergy incidence.

7. Synbiotic trial: L. paracasei B21060 + prebiotics in children with acute diarrhea

  • Journal: Alimentary Pharmacology and Therapeutics, 2012

  • Citations: 70+

  • Key Insight: Demonstrates clinical efficacy of a synbiotic in reducing duration and severity of diarrhea in children.

8. Epigenetic Regulation of Early Nutrition on Immune System

  • Book Chapter: Handbook of Nutrition, Diet, and Epigenetics, 2017

  • Citations: 60+

  • Key Insight: Explores the interplay between early-life nutrition and immune system development via epigenetic pathways.

9. EAACI Position Paper: Diagnosis & Management of Food Allergy-Induced Constipation

  • Journal: Pediatric Allergy and Immunology, 2024; 35(6)

  • Citations: 30+

  • Key Insight: Provides evidence-based recommendations for managing GI symptoms linked to food allergy in young children.

10. Italian Joint Position Paper: Pediatric Food Allergies and Intolerances Pathway

  • Journal: Italian Journal of Pediatrics, 2022

  • Citations: 40+

  • Key Insight: Establishes an integrated clinical pathway for diagnosis, therapy, and follow-up in children with food allergies in Italy.

Conclusion

Prof. Dr. Roberto Berni Canani exhibits all the hallmarks of a world-class researcher: groundbreaking and interdisciplinary work, an enormous impact on both science and clinical practice, and a clear commitment to training future leaders and engaging with the public. His contributions have transformed the understanding and management of pediatric gastroenterology and food-induced diseases, making him eminently deserving of the Best Researcher Award.

Constantin-Ioan Busuioc | Molecular Pathology | Best Researcher Award

Published on by Molecular Biologist

Dr. Constantin-Ioan Busuioc | Molecular Pathology | Best Researcher Award

Pathologist, at Saint Mary Clinical Hospital, Romania.

Dr. Constantin-Ioan Busuioc is a distinguished Romanian pathologist with a strong background in both clinical and research domains. Born on January 29, 1985, he has devoted his career to exploring the intricate dynamics of pathology, with special focus on oncologic and hematologic conditions. He is currently affiliated with Saint Mary Clinical Hospital in Bucharest, where he plays a pivotal role in surgical specimen analysis and histopathological diagnostics. Over the years, Dr. Busuioc has amassed considerable experience across institutions in Romania, Switzerland, and Italy, enriching his expertise in diagnostic pathology. His research contributions, particularly in colorectal cancer and immunohistochemistry, have gained recognition in high-impact journals. Known for his clinical precision and academic depth, he bridges the gap between research and real-world pathology. Dr. Busuioc is fluent in English and French, and actively participates in both national and international medical networks. 🧬💉🧪

Professional Profile

Scopus

🎓 Education

Dr. Constantin-Ioan Busuioc’s educational journey exemplifies dedication to academic excellence in medicine. He completed his Medical Doctor (M.D.) degree at the University of Medicine and Pharmacy “Iuliu Haţieganu” in Cluj-Napoca, Romania (2005–2011) 🩺. Subsequently, he pursued a Ph.D. at the same institution from 2015 to 2022, delving into molecular and immunohistochemical aspects of malignancies, particularly colorectal adenocarcinoma. His rigorous research training culminated in several significant publications and conference presentations. In 2021, he obtained a Certificate in Health Services Management from the National School of Public Health, Management and Training, enhancing his administrative and healthcare policy knowledge 📊. Additionally, he undertook a fellowship in Hematopathology at the prestigious European Institute of Oncology in Milan, Italy, under Prof. Dr. Stefano A. Pileri. This diverse academic path has equipped him with a well-rounded perspective, blending clinical pathology, biomedical research, and health systems management. 📚🧠

🏥 Experience

With over a decade of professional experience, Dr. Busuioc has held key pathology roles across several European institutions. His current role at Saint Mary Clinical Hospital (since 2023) involves high-stakes diagnostics, intraoperative evaluations, and necropsies. From 2021 to 2023, he served at the National Institute of Infectious Diseases “Prof. Dr. Matei Balș”, specializing in infectious pathology, autopsies, and immunohistochemistry. 🧫 Earlier roles include long-term service at Oncoteam Diagnostic and previous tenure at Synevo, where he managed complex diagnostic cases involving general and hematopathology. Internationally, he worked as Chef de Clinique at Valais Hospital in Switzerland (2018–2019) and completed an intensive fellowship at the European Institute of Oncology, Italy. His foundational years were spent as a resident at Cluj-Napoca County Hospital, with rotations at specialized hospitals including the Oncology Institute and Gastroenterology Institute. His vast experience shapes his precision in diagnosis and depth in pathology. 🧬🦠

🧠 Research Interests

Dr. Busuioc’s research interests lie at the intersection of molecular oncology, immunohistochemistry, and epithelial-mesenchymal transition (EMT) in gastrointestinal malignancies, particularly colorectal and esophageal cancers. He is also intrigued by gene expression profiling, diagnostic biomarkers, and tumor microenvironment interactions. 🧬 His studies often explore the role of EMT markers like Vimentin and E-cadherin in predicting tumor progression. Utilizing bioinformatics tools, he analyzes molecular pathways and gene signatures such as MMP3 and TESC, aiming to enhance early detection and personalized treatment approaches. He has contributed significantly to the understanding of PD-L1 expression, particularly in esophageal carcinoma, and its immunological implications. Additionally, he has co-authored studies on rare case presentations such as Kikuchi-Fujimoto disease and lymphomas in gynecological tissues. His collaborative approach and interdisciplinary mindset make his research impactful and translational. 🔍🧫

🏆 Awards

Dr. Constantin-Ioan Busuioc has earned recognition for his commitment to excellence in pathology and oncology research. One of the highlights of his academic career is being part of the UEFISCDI-awarded article published in Cancers (Basel), which offered a comprehensive review of MAPK pathways as therapeutic targets in cancer. 🏅 His insightful contributions to colorectal cancer pathology and bioinformatics analysis have garnered attention in Romanian medical circles and abroad. His consistent publication in high-impact journals reflects a commendable academic rigor. He has also been nominated for multiple academic awards through Romanian and European research forums. His interdisciplinary case studies, particularly in complex co-morbidities, showcase his versatility as both a clinician and a researcher. These recognitions not only validate his scientific acumen but also reinforce his status as a dedicated and innovative medical professional. 🌟📖

📚Top Noted Publications

Dr. Busuioc has co-authored 12+ peer-reviewed articles in reputable international journals, reflecting his impactful work in pathology and molecular oncology:

  1. Aberrant Immunohistochemical Expression in Colorectal Adenocarcinoma
    Chirurgia (Bucur), 2022

    • Focus: Aberrant IHC patterns in colorectal cancer

    • Citations: 5

    • Notes: Highlights novel expression markers potentially linked to prognosis and therapy responsiveness.

  2. MMP3 & TESC in Colon Adenocarcinoma
    BioMedInformatics, 2022

    • Focus: Role of MMP3 and TESC genes in colon cancer progression using computational biology tools

    • Citations: 2

  3. EMT Gene Signature & Prognosis in Colon Adenocarcinoma
    Journal of Personalized Medicine, 2021

    • Focus: EMT-related gene expression linked to prognosis and patient stratification

    • Citations: 10

    • Impact: Widely referenced in personalized therapy literature.

  4. PD-L1 Expression in Esophageal Carcinomas
    Chirurgia (Bucur), 2022

    • Focus: PD-L1 immunostaining in esophageal cancer subtypes

    • Notes: Adds data to the ongoing debate on immunotherapy eligibility.

  5. MAPK Pathways Review: Biological Mechanisms & Therapeutic Targets in Oncology
    Cancers (Basel), 2019

    • Focus: Comprehensive review of MAPK signaling in cancer

    • Citations: 100+

    • Recognition: Award-winning article, highly cited in targeted therapy discussions.

  6. Multidisciplinary Team in Rectal Cancer Management: Integration & Outcomes
    Clujul Med, 2017

    • Focus: Clinical coordination in colorectal cancer treatment

    • Notes: Addresses practical framework for collaborative cancer care.

🩺 Internal Medicine, Autoimmunity & Rare Conditions

  1. Case of Acute Polyarthritis with Severe Comorbidity
    Internal Medicine, 2021

    • Focus: Complex internal medicine case with overlapping rheumatological and systemic features

  2. Sarcoidosis Associated with Solid Pseudopapillary Tumor: A Diagnostic Rarity
    Romanian Journal of Internal Medicine, 2022

    • Focus: Uncommon tumor presentation in a patient with sarcoidosis

  3. Episcleritis in Granulomatosis with Polyangiitis: A Diagnostic Challenge
    Romanian Journal of Ophthalmology, 2021

    • Focus: Ocular manifestation of a systemic vasculitis

  4. Kikuchi-Fujimoto Disease Mimicking Systemic Lupus Erythematosus
    Romanian Journal of Rhinology, 2022

    • Focus: Autoimmune overlap and diagnostic pitfalls

  5. Primary Gynecological Lymphomas: A Behavioural Case Perspective
    Annals of Behavioural Science, 2018

    • Focus: Behavioral and clinical aspects of gynecological lymphoma diagnosis and management

Conclusion

Dr. Constantin-Ioan Busuioc is a strong candidate for a Best Researcher Award, especially in the field of oncopathology, molecular diagnostics, and histopathology. His blend of clinical practice, interdisciplinary research, and international experience makes him highly competitive. With enhanced visibility in research leadership roles and international scholarly forums, his profile would be further elevated to a global best researcher standard.

Muhammad Zohaib Nawaz | bioinformatics | Best Researcher Award

Published on by Molecular Biologist

Assoc Prof Dr . Muhammad Zohaib Nawaz | bioinformatics | Best Researcher Award 

Associate Professor , Jiangsu University , China .

Muhammad Zohaib Nawaz, Ph.D., is an Associate Professor at Jiangsu University, China, specializing in bioinformatics, environmental microbiology, and computational biology. With extensive experience in biofuels research, he has contributed to advancements in metagenomics and microbial genomics, particularly focused on non-coding RNAs in deep-sea microbes. His interdisciplinary approach bridges bioinformatics and environmental biology.

Profile 

Scopus

Education

🎓 Dr. Nawaz completed his Ph.D. in Biology from Shanghai Jiao Tong University, China, in 2017, focusing on bioinformatics and microbial genomics. He holds an M.S. in Bioinformatics (2011) and a B.S. in Bioinformatics (2009) from Government College University, Faisalabad, Pakistan.

Experience

💼 Dr. Nawaz is currently an Associate Professor at Jiangsu University, China. He has held prestigious postdoctoral fellowships at Xiamen University and Jiangsu University, contributing to significant research in biofuels and microbial genomics. Additionally, he has served as an Assistant Professor at the University of Agriculture, Faisalabad, Pakistan, and a bioinformatics analyst in China.

Research Interests

🔬 His research primarily focuses on environmental microbiology, bioinformatics, microbial genomics, and enzymes of environmental and industrial significance. Dr. Nawaz is an expert in omics and meta-omics analysis, non-coding RNA discovery, and bioinformatics tool development for biological data handling.

Awards

🏆 Dr. Nawaz has received numerous accolades, including the Excellent Postdoctoral Award from Jiangsu Province, China, and was recognized as an Outstanding International Student by the Chinese Government in 2016 and 2017. His academic and research excellence has also earned him prestigious research grants.

Publications

📚 Dr. Nawaz has authored several impactful research papers in high-ranking journals. Below are some of his key publications:

  • Xu, Lingxia, Muhammad Zohaib Nawaz, et al. “Modulating the pH profile of vanillin dehydrogenase enzyme from extremophile Bacillus ligniniphilus L1 through computational guided site-directed mutagenesis.” International Journal of Biological Macromolecules (2024). Cited by 5 articles.
  • Muhammad Zohaib Nawaz, Arslan Tariq, et al. “Genome-wide detection of novel cis-encoded small RNAs in psychrophilic bacterium Psychrobacter aquaticus.” Process Biochemistry (2024). Cited by 3 articles.
  • Taolin Ji, Muhammad Zohaib Nawaz, et al. “Lignin biotransformation: Advances in enzymatic valorization and bioproduction strategies.” Industrial Crops and Products 216 (2024). Cited by 7 articles.
  • Muhammad Zohaib Nawaz, et al. “Synthesis of novel metal silica nanoparticles exhibiting antimicrobial potential and applications to combat periodontitis.” Environmental Research 241 (2024). Cited by 9 articles.
  • Muhammad Zohaib Nawaz, Hafiz Rameez Khalid, et al. “Discovery of putative inhibitors of human Pkd1 enzyme: Molecular docking, dynamics and simulation, QSAR, and MM/GBSA.” Environmental Research (2024). Cited by 4 articles.
  • Muhammad Zohaib Nawaz, et al. “Genomic and biotechnological potential of a novel oil-degrading strain Enterobacter kobei DH7 isolated from petroleum-contaminated soil.” Chemosphere (2023). Cited by 6 articles.

Conclusion

Dr. Muhammad Zohaib Nawaz is an outstanding candidate for the Best Researcher Award, with a solid academic foundation, a track record of impactful publications, and leadership in securing research funding. His expertise in bioinformatics and environmental microbiology has the potential to address global challenges, making him a strong contender. With minor improvements in interdisciplinary expansion and public engagement, Dr. Nawaz could further cement his position as a leading researcher in his field.